New hope for kids with rare kidney disease: drug trial aims to slow damage
NCT ID NCT04782258
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 24 times
Summary
This study tests the safety of a drug called tolvaptan in children aged 28 days to 18 years who have a rare inherited kidney disease called ARPKD. The goal is to see if the drug can slow kidney function decline and reduce the need for dialysis or a kidney transplant. About 20 children will take the drug for 18 months while doctors monitor side effects and kidney health.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY (ARPKD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
C.S. Mott Children's Hospital
RECRUITINGAnn Arbor, Michigan, 48109-5000, United States
-
Children's Hospital - New Orleans
WITHDRAWNNew Orleans, Louisiana, 70118, United States
-
Children's Hospital of Pittsburgh of UPMC
WITHDRAWNPittsburgh, Pennsylvania, 15213, United States
-
Children's National Medical Center
RECRUITINGWashington D.C., District of Columbia, 20010, United States
-
Cincinnati Children's Hospital Medical Center
RECRUITINGCincinnati, Ohio, 45229-3039, United States
-
Cleveland Clinic
RECRUITINGCleveland, Ohio, 44195, United States
-
Emory University Hospital
WITHDRAWNAtlanta, Georgia, 30322, United States
-
Great Ormond Street Hospital for Children NHS Trust
RECRUITINGLondon, WC1N 3JH, United Kingdom
-
Hospital Universitari Parc Tauli
WITHDRAWNSabadell, Barcelona, 08208, Spain
-
Hospital Universitari Vall D Hebron
RECRUITINGBarcelona, 8035, Spain
-
Hospital Universitario Virgen del Rocío Avenida Manuel Siurot
WITHDRAWNSeville, 41013, Spain
-
Instytut "Pomnik - Centrum Zdrowia Dziecka"
WITHDRAWNWarsaw, Masovian Voivodeship, 04-730, Poland
-
Johns Hopkins Pediatric Specialty Clinic
RECRUITINGBaltimore, Maryland, 21287, United States
-
Mayo Clinic - Rochester
RECRUITINGRochester, Minnesota, 55905, United States
-
Northwestern University Feinberg School of Medicine - Ann & Robert H. Lurie Children's Hospital of Chicago - Neonatology
WITHDRAWNChicago, Illinois, 60611, United States
-
Primary Children's Hospital
WITHDRAWNSalt Lake City, Utah, 84113, United States
-
Riley Hospital for Children
WITHDRAWNIndianapolis, Indiana, 46202-5119, United States
-
UZ Leuven
RECRUITINGLeuven, Vlaams Brabant, 3000, Belgium
-
Universitair Ziekenhuis Gent
RECRUITINGGhent, Oost-Vlaanderen, 9000, Belgium
-
Universitat de Barcelona - Hospital Sant Joan de Deu Barcelona (HSJDB)
RECRUITINGEsplugues de Llobregat, Barcelona, 8950, Spain
-
Universitätsklinikum Köln
RECRUITINGCologne, North Rhine-Westphalia, 50937, Germany
-
Université Catholique De Louvain And Cliniques St Luc
RECRUITINGBrussels, Brussels Capital, 1200, Belgium
-
Uniwersytecki Dzieciecy Szpital Kliniczny im. L. Zamenhofa
WITHDRAWNBialystok, 15-274, Poland
Conditions
Explore the condition pages connected to this study.